Aethlon Medical, Inc. (AEMD)

Aethlon Medical Income Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	-	-	0.57	0.29	0.66
Revenue Growth (YoY)	-	-	95.21%	-55.37%	1.37%
Gross Profit	-	-	0.57	0.29	0.66
Selling, General & Admin	9.34	12.64	12.47	10.72	8.55
Operating Expenses	9.34	12.64	12.47	10.72	8.55
Operating Income	-9.34	-12.64	-11.9	-10.42	-7.89
Interest Expense	-0.01	-	-	-	-
Interest & Investment Income	0.3	0.45	0.01	-	-
Other Non Operating Income (Expenses)	-4.33	-0.02	-	-	-
EBT Excluding Unusual Items	-13.39	-12.21	-11.89	-10.42	-7.89
Gain (Loss) on Sale of Assets	-	-	-0.14	-	-
Pretax Income	-13.39	-12.21	-12.03	-10.42	-7.89
Earnings From Continuing Operations	-13.39	-12.21	-12.03	-10.42	-7.89
Minority Interest in Earnings	-	-	-	0	0
Net Income	-13.39	-12.21	-12.03	-10.42	-7.89
Net Income to Common	-13.39	-12.21	-12.03	-10.42	-7.89
Shares Outstanding (Basic)	2	0	0	0	0
Shares Outstanding (Diluted)	2	0	0	0	0
Shares Change (YoY)	396.93%	22.35%	39.17%	22.05%	254.06%
EPS (Basic)	-8.58	-38.87	-46.86	-56.47	-52.18
EPS (Diluted)	-8.58	-38.87	-46.86	-56.47	-52.18
Free Cash Flow	-7.65	-10.38	-11.45	-10.12	-6.82
Free Cash Flow Per Share	-4.90	-33.05	-44.59	-54.84	-45.16
Gross Margin	-	-	100.00%	100.00%	100.00%
Operating Margin	-	-	-2072.05%	-3542.53%	-1197.31%
Profit Margin	-	-	-2094.89%	-3540.90%	-1196.58%
Free Cash Flow Margin	-	-	-1993.62%	-3439.01%	-1035.47%
EBITDA	-9	-12.28	-11.66	-10.3	-7.85
D&A For EBITDA	0.34	0.36	0.24	0.12	0.04
EBIT	-9.34	-12.64	-11.9	-10.42	-7.89
Revenue as Reported	-	-	0.57	0.29	0.66

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q